NCT06790823 Effect of Probiotic Supplement on Improvement of Depressive Symptoms in Patients With Substance-Induced Depressive Disorder Status COMPLETED Phase PHASE1/PHASE2
NCT06790693 A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Status RECRUITING Phase PHASE3
NCT06790121 A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT06790095 TRACK-TBI Precision Medicine Part 3 - Option II Status ENROLLING_BY_INVITATION Phase PHASE2
NCT06789913 A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation Status RECRUITING Phase PHASE2
NCT06788990 FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC Status RECRUITING Phase PHASE2/PHASE3
NCT06788522 The Effects of Orexin Antagonism on Fear Extinction in PTSD Status NOT_YET_RECRUITING Phase PHASE4
NCT06788236 Study of Efficacy and Safety of AVTR101 in Sarcopenic Elderly Status TERMINATED Phase PHASE2
NCT06787118 Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT06786936 Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms Status RECRUITING Phase N/A
NCT06786676 A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants Status RECRUITING Phase PHASE1
NCT06786624 Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) Status RECRUITING Phase PHASE3
NCT06785974 Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis Status NOT_YET_RECRUITING Phase PHASE4
NCT06785454 A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension Status COMPLETED Phase PHASE2
NCT06785116 A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP) Status RECRUITING Phase PHASE4
NCT06785012 A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder Status RECRUITING Phase PHASE2
NCT06783881 Single-ascending Dose Study of Kylo-12 in Healthy Subjects Status ACTIVE_NOT_RECRUITING Phase PHASE1